Eva Barragán

9PUBLICATIONS
73CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 08, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|Oct 13, 2025
Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua

|Jul 02, 2025
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression.

Ruba Almaghrabi, Yara Alyahyawi, Peter Keane

|May 12, 2023
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.

Claudia Sargas, Rosa Ayala, María J Larráyoz

|Jul 24, 2021
Correction: Liquori et al. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene. Cancers 2020, 12, 624.

Alessandro Liquori, Mariam Ibañez, Claudia Sargas

Pageof 2

Frequent Collaborators

4 joint publications

Pau Montesinos

3 joint publications

Mar Tormo

3 joint publications

Rosa Ayala

3 joint publications

Maria José Calasanz